Beyond pharmaceutical soy isoflavones


Menopause is a natural transition in the woman life. SOLGENTM is a safe and clinically effective ingredient for menopause related disorders as bone mineral loss, cognitive dysfunctions, cardiovascular diseases and weight gain.

SolgenTM soybean isoflavones has been chosen has the first-line approach to the treatment of menopausal vasomotor complains.

SolgenTM contains the highest levels of genistin & genistein isoflavones, the phytoestrogen that favorably contributes in menopause.

SolgenTM soy isoflavones profile mimics the human body’s natural estrogen.

European Food Safety Association (EFSA) has concluded on the absence of adverse effects with the intake of 35-150mg of isoflavones daily through food or supplements.

The long term use of SOLGENTM soybean isoflavones seems to be protective on breast tissue.

Supplementation with SOLGENTM has been clinically effective in menopause related disorders.

Is the unique soy isoflavones approved for the treatment of hot flashes during menopause (eCTD-DMF available).

Highest bioavailability. Clinically proven